Research Article
Ten-Day versus 14-Day Levofloxacin-Containing Triple Therapy for Second-Line Anti-Helicobacter pylori Eradication in Taiwan
Table 2
The major outcomes of EAL-10 and EAL-14 eradication therapy.
| |||||||||||||||||||||||||||||||||||
EAL-10: esomeprazole/amoxicillin/levofloxacin triple therapy 10 days and EAL-14: esomeprazole/amoxicillin/levofloxacin triple therapy 14 days. |